Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

VIVO Cannabis Inc. V.PDA


Primary Symbol: VVCIF

VIVO Cannabis Inc is a Canada-based company. It is involved in the production and sale of medical and recreational cannabis and the provision of cannabis-related medical information and services in Canada. The company's operating segment includes Cannabis, Patient Clinics, and Corporate. It generates maximum revenue from the Cannabis segment. The company has a presence across three geographical locations - Canada, Germany, and Australia.


OTCQB:VVCIF - Post by User

Comment by 1hot-techwomanon Jun 24, 2021 2:27pm
209 Views
Post# 33444978

RE:RE:Bring on 2022....LOL

RE:RE:Bring on 2022....LOL
1hot-techwoman wrote:
1hot-techwoman wrote:

VIVO Cannabis

VIVO Cannabis (TSXV:VIVO) is a Canadian licensed producer of premium medical-grade cannabis with over 100 years combined experience in international pharmaceuticals. The company offers high-quality cannabis and premium medical products through its Fireside, Beacon Medical, and Lumina brands.

In March of 2019, VIVO received approval for expansion at both its British Columbia and Ontario facilities, adding 4,000 kg of production. This brings the company’s total annual production to 8,000 kg by the end of 2019 and expects to increase that to 13,500 kg by 2020.

VIVO is a leader in the Canadian medical market with the company’s wholly owned Harvest Medicine operating five clinics in four provinces with over 27,000 patients. In Europe, the company has received a wholesale licence in Germany and already has 30,000 patients.

By 2022, the company expects to be making $350 million in domestic and international medical cannabis sales revenue with an additional $150 million in recreational sales. With a net selling price of $7.70 per gram, VIVO premium cannabis remains within the top tier of the industry.



Buy out is in the works !!!


There is so much manipulation going on with this company its disgusting !!! 

<< Previous
Bullboard Posts
Next >>